Genetics of Parkinson's disease: an introspection of its journey towards precision medicine

S Bandres-Ciga, M Diez-Fairen, JJ Kim… - Neurobiology of …, 2020 - Elsevier
ABSTRACT A substantial proportion of risk for Parkinson's disease (PD) is driven by
genetics. Progress in understanding the genetic basis of PD has been significant. So far …

The epidemiology of Parkinson's disease: risk factors and prevention

A Ascherio, MA Schwarzschild - The Lancet Neurology, 2016 - thelancet.com
Since 2006, several longitudinal studies have assessed environmental or behavioural
factors that seem to modify the risk of developing Parkinson's disease. Increased risk of …

Neuroprotective effects of coffee bioactive compounds: a review

K Socała, A Szopa, A Serefko, E Poleszak… - International journal of …, 2020 - mdpi.com
Coffee is one of the most widely consumed beverages worldwide. It is usually identified as a
stimulant because of a high content of caffeine. However, caffeine is not the only coffee …

MDS research criteria for prodromal Parkinson's disease

D Berg, RB Postuma, CH Adler, BR Bloem… - Movement …, 2015 - Wiley Online Library
This article describes research criteria and probability methodology for the diagnosis of
prodromal PD. Prodromal disease refers to the stage wherein early symptoms or signs of PD …

A minireview of quercetin: from its metabolism to possible mechanisms of its biological activities

HG Ulusoy, N Sanlier - Critical Reviews in Food Science and …, 2020 - Taylor & Francis
Quercetin, one of the most taken flavonoid with diet, belongs to the family of flavonols in
which kaempferol and myricetin are also found. Quercetin occurs as a glycoside (with linked …

Caffeine as a factor influencing the functioning of the human body—friend or foe?

K Rodak, I Kokot, EM Kratz - Nutrients, 2021 - mdpi.com
Nowadays, caffeine is one of the most commonly consumed substances, which presents in
many plants and products. It has both positive and negative effects on the human body, and …

[HTML][HTML] Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis

G DeMaagd, A Philip - Pharmacy and therapeutics, 2015 - ncbi.nlm.nih.gov
Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …

Coffee, caffeine, and health outcomes: an umbrella review

G Grosso, J Godos, F Galvano… - Annual review of …, 2017 - annualreviews.org
To evaluate the associations between coffee and caffeine consumption and various health
outcomes, we performed an umbrella review of the evidence from meta-analyses of …

Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses

V Bellou, L Belbasis, I Tzoulaki, E Evangelou… - Parkinsonism & related …, 2016 - Elsevier
Background Parkinson's disease is a neurological disorder with complex pathogenesis
implicating both environmental and genetic factors. We aimed to summarise the …

The neuroprotective effects of caffeine in neurodegenerative diseases

M Kolahdouzan, MJ Hamadeh - CNS neuroscience & …, 2017 - Wiley Online Library
Caffeine is the most widely used psychostimulant in Western countries, with antioxidant, anti‐
inflammatory and anti‐apoptotic properties. In Alzheimer's disease (AD), caffeine is …